SiTRL Lab
SiTRL Lab
Embedded Files
Siriraj Theranostics and Radiopharmaceuticals Laboratory
"SiTRL" is the Laboratory where Radiopharmaceutical science meets precision medicine. We explore the frontiers of radiopharmaceuticals and theranostics—from Tc-99m, Ga-68, and F-18 imaging agents to Lu-177 and Ac-225 targeted therapies—while developing next-generation molecular probes for cancer and neurological diseases.
Our researchers work at the intersection of radiochemistry, radiopharmacy, molecular imaging, and translational medicine to transform innovative discoveries into better patient care and the future of personalized healthcare.
Research Focus
Research Focus
Development and clinical translation of diagnostic radiopharmaceuticals labeled with Tc-99m, Ga-68, and F-18.
Novel PET and SPECT tracers for oncological and non-oncological applications.
Development and clinical application of theranostic agents using Lu-177 and Ac-225. PSMA-targeted radiopharmaceuticals for prostate cancer. Somatostatin receptor-targeted agents, including DOTATATE, for neuroendocrine tumors.
Discovery and evaluation of novel molecular targets and next-generation ligands for precision oncology.
Advanced PET imaging of Alzheimer's disease and related neurodegenerative disorders.
Amyloid imaging using 18F-Florbetapir (18F-AV45).
Tau imaging using 18F-MK6240.
Page updated
Google Sites
Report abuse